237 related articles for article (PubMed ID: 24777709)
21. Congenital nasolacrimal duct obstruction update study (CUP study): Paper II - Profile and outcomes of complex CNLDO and masquerades.
Bansal O; Bothra N; Sharma A; Ali MJ
Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110407. PubMed ID: 33068946
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of buried probe in complex congenital nasolacrimal duct obstruction and evaluation of its success rate post 'probing and irrigation': a single-centre retrospective study.
Gupta N; Chawla N; Ganesh S; Das S; Dhawan N; Bansal S; Singla P
Orbit; 2018 Dec; 37(6):397-400. PubMed ID: 29400586
[TBL] [Abstract][Full Text] [Related]
23. Complex Stenoses and CT Features of the Nasolacrimal Canal in Congenital Nasolacrimal Duct Obstruction.
Fayet B; Racy E; Bordonné C; Katowitz JA; Katowitz WR; Brémond-Gignac D
Ophthalmic Plast Reconstr Surg; 2019; 35(6):594-599. PubMed ID: 31206460
[TBL] [Abstract][Full Text] [Related]
24. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success.
Kashkouli MB; Kassaee A; Tabatabaee Z
J AAPOS; 2002 Dec; 6(6):360-3. PubMed ID: 12506276
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.
Cha DS; Lee H; Park MS; Lee JM; Baek SH
Korean J Ophthalmol; 2010 Oct; 24(5):261-6. PubMed ID: 21052504
[TBL] [Abstract][Full Text] [Related]
26. Surgical management of congenital nasolacrimal duct obstruction; one procedure for all versus all procedures for one.
Kashkouli MB; Karimi N; Khademi B
Curr Opin Ophthalmol; 2019 Sep; 30(5):364-371. PubMed ID: 31219833
[TBL] [Abstract][Full Text] [Related]
27. Management of congenital nasolacrimal duct obstruction in down syndrome.
Landau Prat D; Tadros S; Revere KE; Katowitz JA; Katowitz WR
Eye (Lond); 2023 Mar; 37(4):739-743. PubMed ID: 35379922
[TBL] [Abstract][Full Text] [Related]
28. Factors Predictive of Success in Probing for Congenital Nasolacrimal Duct Obstruction.
Beato J; Mota Á; Gonçalves N; Santos-Silva R; Magalhães A; Breda J; Falcão-Reis F
J Pediatr Ophthalmol Strabismus; 2017 Mar; 54(2):123-127. PubMed ID: 27977034
[TBL] [Abstract][Full Text] [Related]
29. [Congenital nasolacrymal duct obstruction: pulled monocanalicular intubation (Monoka) versus pushed monocanalicular intubation (Masterka)].
Vernat-Tabarly O; Delmas J; Robert PY
J Fr Ophtalmol; 2020 Jun; 43(6):461-466. PubMed ID: 32360081
[TBL] [Abstract][Full Text] [Related]
30. Preloaded Monoka (Lacrijet) and congenital nasolacrimal duct obstruction: Initial results.
Fayet B; Racy E; Ruban JM; Katowitz JA; Katowitz WR; Brémond-Gignac D
J Fr Ophtalmol; 2021 May; 44(5):670-679. PubMed ID: 33836913
[TBL] [Abstract][Full Text] [Related]
31. Unilateral congenital nasolacrimal duct obstruction and amblyopia risk factors.
Badakere A; Veeravalli TN; Iram S; Naik MN; Ali MJ
Clin Ophthalmol; 2018; 12():1255-1257. PubMed ID: 30050276
[TBL] [Abstract][Full Text] [Related]
32. Nasal endoscopy-guided primary nasolacrimal duct intubation for congenital nasolacrimal duct obstruction in children older than 4 years.
Arici C; Oto BB
Int Ophthalmol; 2023 Mar; 43(3):1005-1011. PubMed ID: 36053476
[TBL] [Abstract][Full Text] [Related]
33. Management of Congenital Nasolacrimal Duct Obstruction with Probing, Experience in a Mexican Eye Center.
Zuazo F; Morales OO; Tovilla ML; Castañeda ÁN
Nepal J Ophthalmol; 2019 Jul; 11(22):189-196. PubMed ID: 32792696
[TBL] [Abstract][Full Text] [Related]
34. Results of nasolacrimal duct probing in children between 9-48 months.
Medghalchi A; Mohammadi MJ; Soltani Moghadam R; Dalili H
Acta Med Iran; 2014; 52(7):545-51. PubMed ID: 25135264
[TBL] [Abstract][Full Text] [Related]
35. A Novel One-Stage Obstruction-Based Endoscopic Approach to Congenital Nasolacrimal Duct Obstruction.
Kashkouli MB; Abtahi MB; Sianati H; Mahvidizadeh N; Pakdel F; Kashkouli PB; Abdolalizadeh P
Ophthalmic Plast Reconstr Surg; 2017; 33(5):350-354. PubMed ID: 27636242
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of amblyopia risk factors in congenital nasolacrimal duct obstruction.
Matta NS; Singman EL; Silbert DI
J AAPOS; 2010 Oct; 14(5):386-8. PubMed ID: 21035062
[TBL] [Abstract][Full Text] [Related]
37. Success rates of probing for congenital nasolacrimal duct obstruction at various ages.
Świerczyńska M; Tobiczyk E; Rodak P; Barchanowska D; Filipek E
BMC Ophthalmol; 2020 Oct; 20(1):403. PubMed ID: 33032542
[TBL] [Abstract][Full Text] [Related]
38. Congenital Nasolacrimal Duct Obstruction Update Study (CUP Study): Report III. Analysis of Earlier Failed Probing without Endoscopy Guidance.
Bothra N; Bansal O; Sharma A; Ali MJ
Semin Ophthalmol; 2022 Feb; 37(2):249-252. PubMed ID: 34606409
[TBL] [Abstract][Full Text] [Related]
39. Anisometropia and refractive status in children with unilateral congenital nasolacrimal duct obstruction.
Saleem AA; Siddiqui SN; Wakeel U; Asif M
Taiwan J Ophthalmol; 2018; 8(1):31-35. PubMed ID: 29675347
[TBL] [Abstract][Full Text] [Related]
40. Success Rate of Probing for Congenital Nasolacrimal Duct Obstruction in Children.
Valcheva KP; Murgova SV; Krivoshiiska EK
Folia Med (Plovdiv); 2019 Mar; 61(1):97-103. PubMed ID: 31237856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
